2022 ISBRA Diversity Award
2022 Early Career Investigator Award
2022 ISBRA Tabakoff Award
Jellinek Memorial Fund
The 2024 Jellinek Memorial Fund Award for outstanding contribution to the advancement of knowledge on alcohol/alcoholism, Call for Nominations
Jellinek Memorial Fund Award, 2024 call for nominations
History of awardees
Jellinek Memorial Fund Award History
For more information, please visit the Jellinek Memorial Fund website
ACER Journal Award for Outstanding Paper by an Early Career Investigator
The RSA Publication Committee and ACER leadership is pleased to announce the recipients of the ACER Journal Award for Outstanding Paper by an Early Career Investigator. ACER – Alcoholism: Clinical and Experimental Research – is the journal of both RSA and ISBRA. The committee was impressed with the high quality of the contributions and congratulate all who were nominated.
We are pleased to award two Early Career Investigators:
Anny Gano
SUNY Binghamton (currently at Medical University of South Carolina)
Gano, A., Vore, A.S, Sammakia, M.N., & Deak, T. (2019) Assessment of extracellular cytokines in the hippocampus of the awake behaving rat using large-molecule microdialysis combined with multiplex arrays after acute and chronic ethanolexposure. Alcoholism: Clinical and Experimental Research, 43(4), 640-654.
Ruschelle Leone
Georgia State University
Leone, R.M. & Parrott, D.J. (2019) Acute alcohol intoxication inhibits bystander intervention behavior for sexual aggression among men with high intent to help. Alcoholism: Clinical and Experimental Research, 43(1), 170-179.
Each awardee will receive a $500 check and will be recognized both by RSA, ISBRA and ACER. They will also receive registration for the 2021 annual RSA meeting.
Hiromasa Ishii Memorial Award
For over 40 years, Hiromasa Ishii MD, PhD, Professor Emeritus, Keio University, was an outstanding investigator in the fields of alcohol-induced organ diseases, hepatic metabolism and gastroenterology. With his death on 31 May 2010, from complications of myocardial infarction, his large family of colleagues and friends lost a most productive and fascinating leader.…
…Dr Ishii started his career with an MD from Keio University School of Medicine, and a PhD in gastroenterology and hepatology from Keio University. He then pursued his postdoctoral training with Dr Charles S. Lieber at Bronx VA Medical Center and at Mount Sinai School of Medicine in New York City, during this time, where he began his deep involvement in his lifelong research theme alcohol-mediated liver and pancreatic disease, under his tutelage. Dr Ishii, in collaboration with Dr. Lieber, clarified the role of a new microsomal pathway of ethanol metabolism, then known as microsomal ethanol oxidizing sysytem (MEOS) (now accepted as cytochrome P450 [CYP]2E1). Dr Ishii proved biochemically and immunohistochemically that chronic alcohol consumption stimulated adaptive proliferation of the smooth endoplasmic reticulum in hepatocytes, and this increases metabolism of ethanol and other drugs, thereby explaining both tolerance to ethanol and increased hepatotoxicity of various drugs, anesthetics, and carcinogens. Several important medications, such as anticoagulants and sedatives, show decreased effectiveness in alcoholics because of this increased microsomal CYP2E1 activity. This remarkable finding is a fine tribute to his work as an investigator.
ISBRA commemorates Dr. Ishii's life and career by presenting an award in his name every two years at the ISBRA Congress.
